MedMarket Diligence, LLC

Wound closure, sealing, hemostasis and anti-adhesion products are commanding ever greater caseload as a result of a wide range of formulations that optimize wound healing. A new report from MedMarket Diligence details this global $10 billion market.

The high and growing rate of obesity incidence worldwide and its commensurate costs are driving development and use of multiple treatment options spanning surgery, medical devices and drugs, according to a new MedMarket Diligence report.

The global pandemic of obesity, with particular emphasis in Western economies, is driving the development, marketing and sales of diverse treatment options at an aggressive rate, forecasted in a new report from MedMarket Diligence.

A robust worldwide market for products in wound closure and securement, encompassing fibrin sealants/glues, high strength glues, hemostasis, anti-adhesion and other products is forecasted for 2011 to 2015 in a new MedMarket Diligence report.

With its products filling many niches, established companies making acquisitions, startups still entering the market and clinical practice steadily adopting products in existing and new uses, the sealants, glues market is entering a new phase.

According to research completed by MedMarket Diligence, the success of surgical sealants and glues in clinical practice is enabling them to more deeply penetrate existing markets for sutures and staples, plus capture caseload in new applications.

Multiple technologies that produce desired tissue destruction, excision or other tissue effects are competing with each other to drive a high volume of surgical and interventional procedures and markets, according to a new MedMarket Diligence report.

As well established as the practices are for the management of types 1 and 2 diabetes, a raft of new technologies, from modest to radical, are steadily entering clinical practice and the industry, according to a new report from MedMarket Diligence.

The growing global prevalence of type 1 and 2 diabetes, driven by obesity and other forces, is creating strong clinical demand for a diverse set of diagnosis, monitoring and treatment products that are steadily evolving to better manage the disease.

Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence.